drugset / Trial / NCT00232219

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion

NCT00232219

Phase 4 Completed 200 enrolled Melbourne Health
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion. Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion. Cardioversion involves resetting the heart back to normal with the use of electric current. There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion. Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

Timeline

Start
2003-01
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Fish oil Other / unclassified 6 g

Indications